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NeutrophilInﬂammation is highly regulated by various agents. Unexpectedly, we report here that the damage-
associated molecular pattern S100A9 protein, a potent neutrophil activator and inducer of cytokine
production in monocytes, is not a direct activator of cytokine production in human neutrophils.
However, S100A9 primed IL-8 production in fMLP- and GM-CSF-stimulated neutrophiles via NF-jB
and CREB-1, and NF-jB, STAT3 and STAT5, respectively. Pharmacological inhibition conﬁrmed the
importance of these transcription factors by signiﬁcantly decreasing IL-8 production. This is the
ﬁrst time that a different set of transcription factors are shown to be involved in S100A9-primed
neutrophils in response to proinﬂammatory agonist.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction [6–9]. S100A8, S100A8/A9 and S100A9 are chemoattractant forThe innate immune system, in which neutrophils play a
major role, is the ﬁrst biological barrier against invading patho-
gens. Toll-like and NOD-like receptors are the main receptors
responsible for recognition of pathogens. Engagement of these
receptors initiates an inﬂammatory response via the secretion
of inﬂammatory cytokines/chemokines and the recruitment of
leukocytes. Production of cytokines and chemokines is largely
dependent on transcription factors such as NF-jB and CREB-1,
especially in neutrophils [1,2]. Initiation of the immune response
is also ampliﬁed by secretion and liberation of Damage-
Associated Molecular Patterns (DAMPs) such as HMGB-1 and
S100/calgranulins, which modulate many inﬂammatory functions
[3,4].
S100A8/calgranulin A, S100A9/calgranulin B and S100A12/cal-
granulin C belong to the S100 family of proteins comprising 21
members [5]. S100A8, S100A9 as well as the heterodimer
S100A8/A9 (also named calprotectin) were previously found to
bind to TLR-4, RAGE and some other putative receptors, thereby
modulating various functions of phagocytes and endothelial cellsneutrophils and increase their adhesion [10]. S100A9 also induce
the expression and activation of b2-integrins [11,12]. We recently
demonstrated that S100A9 stimulates neutrophil degranulation
and phagocytosis [13,14]. In addition, S100A8 and S100A9 stimu-
late the secretion of several inﬂammatory cytokines and regulate
the NLRP-3 inﬂammasome, resulting in IL-1b processing and secre-
tion by human monocytes [15].
Neutrophils are exposed to bioactive lipids, cytokines and
DAMPs as they migrate to the inﬂammatory site and, each of these,
stimulate or inhibit their activity. As S100A8 and S100A9 are found
on the endothelium near sites of inﬂammation, we examined the
effect of S100A9 on neutrophil cytokine production. Unexpectedly,
we show here that S100A8 and S100A9 do not directly induce cyto-
kine production in human neutrophils. However, we demonstrate
that S100A9 potentiates IL-8 production by fMLP- or GM-CSF-stim-
ulated neutrophils following NF-jB, CREB-1 and STAT3/STAT5
activation.
2. Materials and methods
2.1. Reagents
Recombinant human S100A8 and S100A9 were produced as
previously described [16]. Cycloheximide, fMLP and anti-b-actin
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AG-490 and the CBP–CREB interaction inhibitor were purchased
from Calbiochem (San Diego, CA). Phospho-IKK-a/b (Ser176/177),
phospho-IKK-c (Ser376), phospho-CREB-1/ATF-1, phospho-STAT-
3, phospho-STAT-5, phospho-STAT-6 and IjB-a antibodies were
purchased from Cell Signaling Technology (Danvers, MA). GAPDH
(FL), STAT-3 and CREB-1 antibodies were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA). RPMI 1640, HEPES, penicillin/
streptomycin (Pen/Strep), heat-inactivated fetal bovine serum
(FBS) was from Life Technologies (Camarillo, CA). Ficoll-Paque
was obtained from GE Healthcare Bio-Science AB (Uppsala,
Sweden). All secondary antibodies were purchased from Jackson
Immuno-Research Laboratories (West Grove, PA). Proteome Proﬁl-
er Array (Human Cytokine Array Panel A) was purchased from R&D
Systems (Minneapolis, MN). Ultrapure-LPS (from Escherichia coli)
were purchased from Invivogen (San Diego, CA). GM-CSF was from
Peprotech (Rocky Hill, NJ).
2.2. Neutrophil isolation
Blood samples were obtained from informed, consenting indi-
viduals according to institutionally approved procedures as previ-
ously described [13]. Cell viability was monitored by trypan blue
exclusion and found to be consistently higher than 99%. Neutro-
phils were suspended at 10  106 cells/ml in RPMI 1640 containing
10% autologous decomplemented serum.
2.3. Cell stimulation
Neutrophil were stimulated with S100A8 (10 lg/ml), S100A9
(10 lg/ml), LPS (100 ng/ml) or the equivalent volume of diluent
(Hank’s Balanced Salt Solution 1X) at 37 C for various period of
time, as speciﬁed. In some experiments, cells were primed for
30 min with S100A8 (10 lg/ml) or S100A9 (10 lg/ml) and then
stimulated with fMLP (107M), GM-CSF (65 ng/mL) or the equiva-
lent volume of diluent for 30 min at 37 C for Western-blots or 24 h
for measurement of cytokines.
2.4. Western blot analysis
After stimulation, the cells were lysed in Laemmli’s sample buf-
fer (0.25 M Tris–HCl [pH 6.8], 8% SDS, 40% glycerol, and 20% 2-ME),
and aliquots of extracts corresponding to 1  106 cells were loaded
onto 10% SDS–PAGE and transferred to nitrocellulose membranes
for the detection of speciﬁc proteins. Membranes were blocked
for 1 h at room temperature in 3% dry fat milk. The primary anti-
bodies were added at a ﬁnal dilution of (1:1000) in TBS-Tween
0.15%. The membranes were kept overnight at 4 C, then washed
with TBS-Tween and incubated for 1 h at room temperature with
a goat anti-rabbit IgG HRP secondary Ab (Jackson ImmunoResearch
Laboratories, West Grove, PA) diluted 1:20000 in TBS-Tween or a
goat anti-mouse IgG HRP secondary Ab (Jackson ImmunoResearch
Laboratories) diluted at 1:20000 in TBS-Tween followed by several
washes. Protein expression was revealed with Luminata Forte
Western HRP Substrate (Millipore) using ChemiDoc™ MP Imaging
System (Bio-Rad). Membranes were stripped with ReBlot Plus
Strong (Millipore) and stained with Amido-black to conﬁrm equal
loading of proteins.
2.5. Electromobility shift assay
Nuclear extracts from cells stimulated for 1 h were prepared
using NucBuster protein extraction kit from Novagen. Electropho-
retic mobility shift assay (EMSA) reaction was done using Gel Shift
Assay System from Promega, as previously described [15].2.6. NF-jB p50 TransFactor ELISA assay
Assays were done according to the Colorimetric TransFactor
ELISA kit Procedure (Clontech Laboratories) as previously
described [15].
2.7. Proteome proﬁler™ array
Human Cytokine Array Panel A were purchased from R&D Sys-
tems (Minneapolis, MN, USA) and all the steps were performed
within 2 weeks following experiments. Cells from 7 different
donors of PMNs were stimulated for 24 h with the corresponding
agonists. Supernatants were then pooled together and used to
probe the membranes as previously described [15]. The chemilu-
minescent signal from the bound cytokines present in the superna-
tants was detected by chemiluminescence using ChemiDoc™ MP
Imaging System.
2.8. IL-8 production
The measurement IL-8 was done using a commercially available
enzyme-linked-immunosorbent assay (ELISA) kit (Life Technolo-
gies) according to the manufacturer’s instructions.
2.9. Statistical analysis
Experimental data are expressed as mean ± S.E.M. One-way
ANOVA (Dunnett multiple-comparison test) and two-way ANOVA
(Bonferroni post-test) were performed using Graph-Pad Prism
(version 5.01). Differences were considered statistically signiﬁcant
as follows: ⁄P 6 0.05, ⁄⁄P 6 0.01, and ⁄⁄⁄P 6 0.005 versus buffer or
the appropriate diluent.
3. Results
3.1. S100A8 and S100A9 do not induce cytokine production in human
neutrophils
We recently reported that S100A8 and S100A9 induce inﬂam-
matory cytokine expression and secretion by human monocytes
[15]. As both of these DAMPs are potent neutrophil activators
[13–15], we investigated their effects on cytokine production.
Surprisingly, neither S100A8 nor S100A9 were found to induce
cytokine secretion as assessed by an antibody array assay
(Fig. 1A). To conﬁrm this, we next quantiﬁed the IL-8 production
using a speciﬁc ELISA kit. As illustrated in Fig. 1B, unlike LPS,
S100A8 or S100A9 did not signiﬁcantly increase the IL-8
production.
3.2. Lack of NF-jB activation by S100A8 and S100A9, although S100A9
increased IKK-c phosphorylation
Since we have previously shown that S100A8 and S100A9
induced NF-jB activation in human monocytes, we next investi-
gated the effect of S100A8 and S100A9 on NF-jB translocation/
activation in human neutrophils. EMSA analyses revealed that nei-
ther S100A8 nor S100A9 induced NF-jB translocation/activation
(Fig. 2A). These results were conﬁrmed using the NF-jB p50 Trans-
Factor Assay (Fig. 2B). Curiously, S100A9, but not S100A8, signiﬁ-
cantly increased the phosphorylation of IKK-c. However,
phosphorylation of IKK-a/b and degradation of IjB-a was not
observed in S100A8 and S100A9-treated cells (Fig. 2C). In addition,
kinetic experiments in S100A8 and S100A9-treated cells revealed
that the expression level of IjB-a remained unchanged at 30, 60,
120 and 180 min (data not shown). Only the positive control LPS
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Fig. 1. S100A8 and S100A9 do not induce cytokine and chemokine expression in human neutrophils. Cytokine production was evaluated using proteome proﬁler arrays (A) or
ELISA (B). Neutrophils (106 cells/mL) were stimulated with S100A8 (10 lg/mL), S100A9 (10 lg/mL), LPS (1 lg/mL) or the equivalent volume of diluent (Ctrl) for 24 h.
Supernatants were harvested and used for experiments. Data represent supernatants pooled from 10 different blood donors (A). Data are mean ± S.E.M. of four experiments
performed on cells from different donors (B). Boxes, localization of IL-8 (duplicate) on the membrane. The cytokine array coordinates are: Positive Ctrl (A1,A2); C5a (A3,A4);
CD40 ligand (A5–6); G-CSF (A7,A8); GM-CSF (A9,A10); CXCL1/GROa (A11,A12); CCL1/I-309 (A13,A14); sICAM-1 (A15,A16); IFN-c (A17,A18); Positive Ctrl (A19,A20); IL-1a
(B3,B4); IL-1b (B5,B6); IL-1ra (B7,B8); IL-2 (B9,B10); IL-4 (B11,B12); IL-5 (B13,B14); IL-6 (B15,B16); IL-8 (B17,B18) IL-10 (C3,C4); IL-12p70 (C5,C6); IL-13 (C7,C8); IL-16
(C9,C10); IL-17 (C11,C12); IL-17E (C13,C14); IL-23 (C15,C16); IL-27 (C17,C18); IL-32a (D3,D4); CXCL10/IP-10 (C5,D6); CXCL11/I-TAC (D7,D8); CCL2/MCP-1 (D9,D10); MIF
(D11,D12); CCL3/MIP-1a (D13,D14); CCL4/MIP-1b (D15,D16); Serpin E1/PAI-1 (D17,D18); Positive Ctrl (E1,E2); CCL5/RANTES (E3,E4); CXCL12/SDF-1 (E5,E6); TNF-a (E7,E8);
sTREM-1 (E9,E10); Negative Ctrl (E19,E20).
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Fig. 2. S100A8 and S100A9 do not increase translocation of NF-jB in human neutrophils. Translocation and binding of NF-jB was assessed by EMSA (A) and with a NF-kB p50
TransFactor ELISA kit (B), as described in Section 2. Nuclear proteins were isolated from cells stimulated for 1 h. Lanes 1, 3, 5 and 7 (c, competitive assay). Lanes 2, 4, 6 and 8
(non-competitive assay). Phosphorylation of the IKK complex and degradation of IjB-a was assessed by Western blot experiments (C). Results are from one representative
experiment of at least four others (A and C). Data are means ± S.E.M. of three experiments performed on cells from different blood donors (B).
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dation of IjB-a and translocation of NF-jB.
3.3. S100A9 potentiates the fMLP- or GM-CSF-induced cytokine
production in neutrophils
Because IKK-c is the non-catalytic regulatory subunit of the IKK
complex [17] and since S100A9 increased IKK-c phosphorylation,
we reasoned that this protein could be involved in the regulation
of cytokine production. S100A9 is found on endothelium near sites
of extravasation and could therefore prime neutrophils to respond
to cytokines found at the inﬂammatory site. To mimic the presence
of S100A9 in inﬂammatory settings, neutrophils were primed with
S100A9 prior to treatment with GM-CSF or fMLP. Interestingly,
although S100A9 had no effect on cytokine secretion, it primed
the effect of GM-CSF and fMLP on IL-8 secretion (Fig. 3). In contrast,S100A8 did not affect the secretion of IL-8 induced by either fMLP
or GM-CSF (data not shown).
3.4. Role of the transcription factors in response to GM-CSF or fMLP-
induced IL-8 production in S100A9-primed neutrophils
We next determined the effect of S100A9 on various transcrip-
tion factors known to be involved in the regulation of IL-8. Priming
of neutrophils with S100A9 promoted the degradation of IjB-a and
translocation of the NF-jB p50 subunit to the nucleus in response
to GM-CSF and fMLP (Fig. 4A and B). In addition, S100A9 led to the
phosphorylation of CREB-1/ATF-1 (Fig. 4C). However, S100A9, by
itself, did not induce STAT-3 or STAT-5 phosphorylation directly
but induced a signiﬁcant increase in the phosphorylation levels
of these proteins following GM-CSF activation. Phosphorylation
levels of STAT-6 remained unchanged in all tested conditions.
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Fig. 3. S100A9 potentiates the IL-8 secretion in human neutrophils treated with fMLP and GM-CSF. Cytokine production was evaluated using proteome proﬁler arrays (A) or
ELISA (B). Neutrophils (10  106 cells/mL) were pre-treated S100A9 (10 lg/mL) or the equivalent volume of diluent (Ctrl) for 30 min. Cells were then stimulated with fMLP
(107 M) or GM-CSF (65 ng/mL) or the equivalent volume of diluent for a total of 24 h. Supernatants were then harvested and used for experiments. Data represent
supernatants pooled from 7 different blood donors (A). Data are mean ± S.E.M. of four experiments performed on cells from different blood donors (B). Boxes, localization of
IL-8 (duplicate) on the membrane.
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importance of these transcription factors in the priming effect of
S100A9 on IL-8 production. Inhibition of NF-jB blocked almost
completely the priming effect induced by S100A9 in both fMLP
or GM-CSF treated neutrophils. Furthermore, while inhibition of
the JAK/STAT pathway by the AG-490 inhibitor reversed speciﬁ-
cally the effect of S100A9 on GM-CSF-induce IL-8 production, inhi-
bition of CREB-1 by the CREB/EBP inhibitor resulted in a partial
decreased level of IL-8 in response to fMLP (Fig. 5).
4. Discussion
Neutrophils play a crucial role in host defense and immunity,
contributing to pathogen clearance and to the recruitment of otherP-IKK-γ
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Fig. 4. S100A9 potentiates the effect of fMLP or GM-CSF on transcription factors NF-jB, C
of IjB-a, phosphorylation of CREB-1/ATF-1, STAT-3, STAT-5 and STAT-6 were assessed
TransFactor ELISA kit (B), as described in Section 2. Neutrophils (10  106 cells/mL) were
(107 M), GM-CSF (65 ng/mL) or the diluent was then added for 30 min. Total proteins
transfactor assay, as described in Section 2. Results are from one representative experim
performed on cells from different blood donors (B).leukocytes through secretion of inﬂammatory mediators [18].
Among these, S100A8 (MRP8) and S100A9 (MRP14) are two
inﬂammatory proteins highly expressed by neutrophils and found
at inﬂammatory sites. Binding of S100A8 and S100A9 to TLR-4
leads to the activation of NF-jB and secretion of inﬂammatory
cytokines in murine BMC and THP-1 cells [6,19]. In addition, stud-
ies have reported important roles for S100A8, S100A8/A9 and
S100A9 in the regulation of cytokine secretion by monocytes
[15,19,20]. However, only one study reported an effect of S100A8
on the secretion of IL-8 and IL-16 by human neutrophils [21]. This
discrepancy might be explained by the fact this study used GST-
tagged-S100A8 with a molecular weight of 36 kDa instead of
the 8 kDa for human S100A8 protein. Also, S100A8 is very sensitive
to oxidation, thereby modifying its inﬂammatory functions. In thisP-CREB-1 (43 Kda) 
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Fig. 5. S100A9 potentiates the secretion of IL-8 in fMLP and GM-CSF-treated neutrophils by two distinct mechanisms. Cytokine production was evaluated by ELISA.
Neutrophils (10  106 cells/mL) were incubated for 30 min with BAY-117082 (10 lM), AG-490 (20 lM), CREB/CBPi (5 lM) or the equivalent volume of DMSO. Cells were then
primed with S100A9 (10 lg/mL) or the equivalent volume of diluent (Ctrl) for 30 min. Cells were then stimulated with fMLP (107 M), GM-CSF (65 ng/mL) or the equivalent
volume of diluent for a total of 24 h. Supernatants were then harvested for quantiﬁcation of IL-8 by ELISA. Data are mean ± S.E.M. of four experiments performed on cells from
different blood donors.
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direct effect on the secretion of cytokines. However, S100A9, but
not S100A8, primed neutrophils to secrete IL-8 in response to
GM-CSF or fMLP by partially activating NF-jB.
Intriguingly, S100A8 and S100A9 had no effect on the secretion
of inﬂammatory cytokines or the activation of transcription factors
in neutrophils, with the notable exception of S100A9 which led to
the direct phosphorylation of CREB-1, without affecting IL-8 con-
centration. These results suggest that secretion of IL-8 is not solely
dependent on phosphorylation of CREB-1 in neutrophils and that
phosphorylation of CREB induced by S100A9 could be involved in
other neutrophil functions.
Several transcription factors including CREB-1, NF-jB and
STATs regulate cytokine production in neutrophils [2,22,23]. A
few studies reported a direct effect of MRPs on translocation of
NF-jB in murine BMC, THP-1 and human prostate cancer cells
[6,19,24]. We have also shown that S100A8 and S100A9 induce
NF-jB translocation and activation in human monocytes [15].
The NF-jB canonical pathway is regulated by members of the
IKK family [17]. IKK-a and IKK-b are two protein kinases that
mediate the phosphorylation and the degradation of IjB-a,
involved in NF-jB inhibition [25]. The IKK complex also comprises
IKK-c, the essential modulator of this complex [26]. Our results
show that S100A9 does not induce IKK-a/b phosphorylation in
neutrophils, explaining the lack of IjB-a degradation and the
absence of the NF-jB p50 subunit in the nucleus. However,
S100A9 induced a strong phosphorylation of IKK-c. Moreover,
priming by S100A9 led to increased levels of NF-jB present in
the nucleus in response to GM-CSF and fMLP. Our results suggest
that S100A9 regulates NF-jB activity through regulation of the
IKK-c subunits. Results in this study also indicate that even if a
potent neutrophil activator such as S100A9 does not directly
induce pro-inﬂammatory cytokine production by itself, it can
potentiate the secretion induced by other neutrophil activators,
including a cytokine like GM-CSF or bacterial products such as
fMLP by recruiting a different set of transcription factors.
Previous work from our laboratory showed that S100A8 and
especially S100A9 regulate various functions in neutrophils includ-
ing adhesion, degranulation, migration and phagocytosis
[10,11,13,14]. S100A8 and S100A9 were also shown to be potent
chemoattractants for neutrophils [10,27] and are important forhost defense and clearance of various pathogens [28–30]. As IL-8
is one of the most potent chemoattractant for neutrophils and
other leukocytes, data presented here suggest a new regulatory
role for S100A9 by contributing to the secretion of this chemokine.
IL-8 has important immunological roles other than the recruitment
of neutrophils to the site of inﬂammation, it also contributes to the
cross-talk between neutrophils and other immune cells such as
Th17 [31] highly involved in the inﬂammatory process.
The above observations, together with the results of the present
study, lead to a plausible scenario regarding the role of S100A9 in
inﬂammation. It can be hypothesized that neutrophils encounter a
series of stimuli as they migrate from the blood to the inﬂamma-
tory site, one of the ﬁrst being S100A9 deposited on the endothe-
lium by migrating myeloid cells [32]. S100A9 would then
activate neutrophils, although not sufﬁciently to induce the secre-
tion of cytokines in the blood. However, primed neutrophils would
secrete more IL-8 once activated by GM-CSF or fMLP in the tissue.
This would in turn lead to an enhanced recruitment of neutrophils
to the inﬂammatory site as observed in vivo in models of bacterial
infection [27,28].
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